Skip to main content
SpringerLink
Log in

New Cancers Among Long-Term Survivors of Retinoblastoma

  • Chapter
  • First Online:
Tumors of the Central Nervous System, Volume 8

Part of the book series: Tumors of the Central Nervous System ((TCNS,volume 8))

  • 1406 Accesses

Abstract

Patients who survive retinoblastoma (RB), particularly those affected by the hereditable bilateral form, are at risk for developing additional malignant neoplasms, including bone and soft-tissue sarcomas, melanoma, brain tumors and a variety of epithelial malignancies. According to current literature, the development of second malignancies in survivors of RB is due to a combination of genetic factors, treatment received, particularly radiotherapy, and environmental factors. The raised risk for second malignancies in RB patients emphasizes the need for lifelong surveillance for early detection and for the control of environmental and behavioral risk factors, such as UV exposure and cigarette smoking.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abramson DH (2005) Retinoblastoma in the 20th century: past success and future challenges. The Weisenfeld lecture. Invest Ophthalmol Vis Sci 46:2683–2691

    Article  PubMed  Google Scholar 

  • Abramson DH, Frank CM (1998) Second nonocular tumors in survivors of bilateral retinoblastoma: a possible age effect on radiation-related risk. Ophthalmology 105:573–579

    Article  PubMed  CAS  Google Scholar 

  • Abramson DH, Ronner HJ, Ellsworth RM (1979) Second tumors in nonirradiated bilateral retinoblastoma. Am J Ophthalmol 87:624–627

    PubMed  CAS  Google Scholar 

  • Acquaviva A, Ciccolallo L, Rondelli R, Balistreri A, Ancarola R, Cozza R, Hadjistilianou D, Francesco SD, Toti P, Pastore G, Haupt R, Carli M, Santoro N, Di Cataldo A, Fiorillo A, Indolfi P, Nucci P, Sandri A, Porta F, Porcaro AB, Tamaro P, Morgese G (2006) Mortality from second tumour among long-term survivors of retinoblastoma: a retrospective analysis of the Italian retinoblastoma registry. Oncogene 25:5350–5357

    Article  PubMed  CAS  Google Scholar 

  • Balmer A, Zografos L, Munier F (2005) Diagnosis and current management of retinoblastoma. Oncogene 25:5341–5349

    Article  Google Scholar 

  • Boltze C, Roessner A, Landt O, Szibor R, Peters B, Schneider-Stock R (2002) Homozygous proline at codon 72 of p53 as a potential risk factor favoring the development of undifferentiated thyroid carcinoma. Int J Oncol 2:1151–1154

    Google Scholar 

  • Draper GJ, Sanders BM, Kingston JE (1986) Second primary neoplasms in patients with retinoblastoma. Br J Cancer 53:661–671

    Article  PubMed  CAS  Google Scholar 

  • Elias WJ, Lopes MB, Golden WL, Jane JA Sr, Gonzalez-Fernandez F (2001) Trilateral retinoblastoma variant indicative of the relevance of the retinoblastoma tumor-suppressor pathway to medulloblastomas in humans. J Neurosurg 95:871–878

    Article  PubMed  CAS  Google Scholar 

  • Eng C, Li FP, Abramson DH, Wong FL, Goldman MB, Seddon J, Tarbell N, Boice JD Jr (1993) Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst 85:1121–1128

    Article  PubMed  CAS  Google Scholar 

  • Fletcher O, Easton D, Anderson K, Gilham C, Jay M, Peto J (2004) Lifetime risks of common cancers among retinoblastoma survivors. J Natl Cancer Inst 96:357–363

    Article  PubMed  Google Scholar 

  • Franchi A, Sardi I, Cetica V, Buccoliero A, Giordano F, Mussa F, Genitori L, Oliveri G, Miracco C (2009) Pediatric sinonasal neuroendocrine carcinoma after treatment of retinoblastoma. Hum Pathol 40:750–755

    Article  PubMed  Google Scholar 

  • Goodrich DW (2006) The retinoblastoma tumor-suppressor gene, the exception that proves the rule. Oncogene 25:5233–5243

    Article  PubMed  CAS  Google Scholar 

  • Goodrich DW, Wang NP, Qian YW, Lee EY, Lee WH (1991) The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell 67:293–302

    Article  PubMed  CAS  Google Scholar 

  • Greger V, Schirmacher P, Bohl J, Bornemann A, Hurter T, Passarge E, Horsthemke B (1990) Possible involvement of the retinoblastoma gene in undifferentiated sinonasal carcinoma. Cancer 66:1954–1959

    Article  PubMed  CAS  Google Scholar 

  • Hamel N, Black MJ, Ghadirian P, Foulkes WD (2000) No association between p53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck. Br J Cancer 82:757–759

    Article  PubMed  CAS  Google Scholar 

  • Harbour JW, Lai SL, Whang-Peng J, Gazdar AF, Minna JD, Kaye FJ (1988) Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science 241:353–357

    Article  PubMed  CAS  Google Scholar 

  • Kleinerman RA, Tucker MA, Tarone RE, Abramson DH, Seddon JM, Stovall M, Li FP, Fraumeni JF Jr (2005) Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J Clin Oncol 23:2272–2279

    Article  PubMed  Google Scholar 

  • Kleinerman RA, Tucker MA, Abramson DH, Seddon JM, Tarone RE, Fraumeni JF Jr (2007) Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma. J Natl Cancer Inst 99:24–31

    Article  PubMed  Google Scholar 

  • Knudson AG (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820–823

    Article  PubMed  Google Scholar 

  • MacCarthy A, Bayne AM, Draper GJ, Eatock EM, Kroll ME, Stiller CA, Vincent TJ, Hawkins MM, Jenkinson HC, Kingston JE, Neale R, Murphy MF (2009) Non-ocular tumours following retinoblastoma in Great Britain 1951 to 2004. Br J Ophthalmol 93:1159–1162

    Article  PubMed  CAS  Google Scholar 

  • Marcus DM, Carpenter JL, O’Brien JM, Kivela T, Brauner E, Tarkkanen A, Virtanen I, Albert DM (1991) Primitive neuroectodermal tumor of the midbrain in a murine model of retinoblastoma. Invest Ophthalmol Vis Sci 32:293–301

    PubMed  CAS  Google Scholar 

  • Marcus DM, Brooks SE, Leff G, McCormick R, Thompson T, Anfinson S, Lasudry J, Albert DM (1998) Trilateral retinoblastoma: insights into histogenesis and management. Surv Ophthalmol 43:59–70

    Article  PubMed  CAS  Google Scholar 

  • Marees T, van Leeuwen FE, de Boer MR, Imhof SM, Ringens PJ, Moll AC (2009) Cancer mortality in long-term survivors of retinoblastoma. Eur J Cancer 45:3245–3253

    Article  PubMed  CAS  Google Scholar 

  • Marees T, van Leeuwen FE, Schaapveld M, Imhof SM, de Boer MR, Kors WA, Ringens PJ, Moll AC (2010) Risk of third malignancies and death after a second malignancy in retinoblastoma survivors. Eur J Cancer 46(11):2052–2058

    Article  PubMed  CAS  Google Scholar 

  • McWilliams JE, Evans AJ, Beer TM, Andersen PE, Cohen JI, Everts EC, Henner WD (2000) Genetic polymorphisms in head and neck cancer risk. Head Neck 22:609–617

    Article  PubMed  CAS  Google Scholar 

  • Meadows AT, Shields CL (2004) Regarding chemoreduction for retinoblastoma and intracranial neoplasms. Arch Ophthalmol 122:1570

    Article  PubMed  Google Scholar 

  • Moll AC, Imhof SM, Schouten-Van Meeteren AY, Kuik DJ, Hofman P, Boers M (2001) Second primary tumors in hereditary retinoblastoma: a register-based study, 1945–1997: is there an age effect on radiation-related risk? Ophthalmology 108:1109–1114

    Article  PubMed  CAS  Google Scholar 

  • Moll AC, Imhof SM, Schouten-van Meeteren AY, Boers M (2002) Screening for pineoblastoma in patients with retinoblastoma. Arch Ophthalmol 120:1774

    PubMed  Google Scholar 

  • Moll AC, Imhof SM, Bouter LM, Kuik DJ, Den Otter W, Bezemer PD, Koten JW, Tan KE (1996) Second primary tumors in patients with hereditary retinoblastoma: a register-based follow-up study, 1945–1994. Int J Cancer 67:515–519

    PubMed  Google Scholar 

  • Roarty JD, McLean IW, Zimmerman LE (1988) Incidence of second neoplasms in patients with bilateral retinoblastoma. Ophthalmology 95:1583–1587

    PubMed  CAS  Google Scholar 

  • Saw D, Chan JK, Jagirdar J, Greco MA, Lee M (1992) Sinonasal small cell neoplasm developing after radiation therapy for retinoblastoma: an immunohistologic, ultrastructural, and cytogenetic study. Hum Pathol 23:896–899

    Article  PubMed  CAS  Google Scholar 

  • Soulitzis N, Sourvinos G, Dokianakis DN, Spandidos DA (2002) p53 codon 72 polymorphism and its association with bladder cancer. Cancer Lett 179:175–183

    Article  PubMed  CAS  Google Scholar 

  • Travis LB, Rabkin CS, Brown LM, Allan JM, Alter BP, Ambrosone CB, Begg CB, Caporaso N, Chanock S, DeMichele A, Figg WD, Gospodarowicz MK, Hall EJ, Hisada M, Inskip P, Kleinerman R, Little JB, Malkin D, Ng AK, Offit K, Pui CH, Robison LL, Rothman N, Shields PG, Strong L, Taniguchi T, Tucker MA, Greene MH (2006) Cancer survivorship – genetic susceptibility and second primary cancers: research strategies and recommendations. J Natl Cancer Inst 98:15–25

    Article  PubMed  Google Scholar 

  • Wong FL, Boice JD Jr, Abramson DH, Tarone RE, Kleinerman RA, Stovall M, Goldman MB, Seddon JM, Tarbell N, Fraumeni JF Jr, Li FP (1997) Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA 278:1262–1267

    Article  PubMed  CAS  Google Scholar 

  • Xu HJ, Hu SX, Cagle PT, Moore GE, Benedict WF (1991) Absence of retinoblastoma protein expression in primary non-small cell lung carcinomas. Cancer Res 51:2735–2739

    PubMed  CAS  Google Scholar 

  • Yarbrough WG, Aprelikova O, Pei H, Olshan AF, Liu ET (1996) Familial tumor syndrome associated with a germline nonfunctional p16INK4a allele. J Natl Cancer Inst 88:1489–1491

    Article  PubMed  CAS  Google Scholar 

  • Yu CL, Tucker MA, Abramson DH, Furukawa K, Seddon JM, Stovall M, Fraumeni JF Jr, Kleinerman RA (2009) Cause-specific mortality in long-term survivors of retinoblastoma. J Natl Cancer Inst 101:581–591

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Pathological Anatomy, Department of Critical Care Medicine and Surgery, University of Florence, Florence, Italy

    Alessandro Franchi

Authors
  1. Alessandro Franchi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alessandro Franchi .

Editor information

Editors and Affiliations

  1. , Kean University, Room 213, Library building, Morris Avenue 1000, Union, 07083, New Jersey, USA

    M.A. Hayat

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Franchi, A. (2012). New Cancers Among Long-Term Survivors of Retinoblastoma. In: Hayat, M. (eds) Tumors of the Central Nervous System, Volume 8. Tumors of the Central Nervous System, vol 8. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-4213-0_16

Download citation

  • DOI: https://doi.org/10.1007/978-94-007-4213-0_16

  • Published:

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-007-4212-3

  • Online ISBN: 978-94-007-4213-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation